Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma
Yarui Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuchen Jiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Siyuan He(Tongji University), Pinli Yue(Chinese Academy of Medical Sciences & Peking Union Medical College), Aiai Gao(Chinese PLA General Hospital), Mingzhou Guo(Chinese PLA General Hospital), Yun Liu(Jiangnan University), Yifei Li(Tongji University), Mo Li(Shenyang Center for Disease Control and Prevention), Ying Zhang(Sun Yat-sen University), Dandan Zhang(Qingdao University), Beibei Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Pei Wang(Icahn School of Medicine at Mount Sinai), Xiaobing Wang(Shanghai Changzheng Hospital), Jinge Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Qing Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Huihui Yin(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 20
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
|Nature|2010|1.8k
<i>DAXX</i> / <i>ATRX</i> , <i>MEN1</i> , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
|Science|2011|1.7k
Proteogenomic characterization of human colon and rectal cancer
|Nature|2014|1.6k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k